Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-04-01 20:00:12 ET · period of report 2026-03-31 · accession 0001873796-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-01 20:00 | 2026-03-31+ | CAPR | Sabar Karimah Es | Dir | M - OptEx | $4.86 | +115.0K | 53.7K | New | +$558.9K |
| DMT | 2026-04-01 20:00 | 2026-03-31+ | CAPR | Sabar Karimah Es | Dir | S - Sale+OE | $30.57 | -115.0K | 0 | -100% | -$3.52M |
| DMT | 2026-04-01 20:00 | 2026-03-31+ | CAPR | Sabar Karimah Es | Dir | M - OptEx | $0.00 | -115.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | M | A | 61,265 | $4.86 | 61,265 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-31 | S | D | 61,265 | $30.17 | 0 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F2) The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive. |
| 3 | Common | Common Stock | 2026-04-01 | M | A | 53,735 | $4.86 | 53,735 | D | — | — | |
| 4 | Common | Common Stock | 2026-04-01 | S | D | 53,735 | $31.03 | 0 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F3) The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-03-31 | M | D | 61,265 | $0.00 | 53,735 | D | $4.86 · — to 2031-07-23 | 61,265 Common Stock | (F4) Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-04-01 | M | D | 53,735 | $0.00 | 0 | D | $4.86 · — to 2031-07-23 | 53,735 Common Stock | (F4) Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022. |